| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.49B | 25.91B | 23.16B | 21.55B | 20.71B | 20.41B |
| Gross Profit | 23.49B | 22.30B | 22.21B | 21.30B | 20.29B | 20.14B |
| EBITDA | 3.03B | 3.55B | 3.33B | 3.06B | 3.50B | 3.20B |
| Net Income | 1.52B | 1.97B | 1.82B | 1.53B | 1.88B | 1.66B |
Balance Sheet | ||||||
| Total Assets | 1.38T | 1.39T | 1.36T | 1.34T | 1.31T | 1.40T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 114.00B | 108.83B | 101.97B | 86.56B | 196.34B |
| Total Debt | 40.03B | 39.99B | 39.98B | 39.34B | 25.44B | 120.55B |
| Total Liabilities | 1.32T | 1.33T | 1.31T | 1.29T | 1.26T | 1.35T |
| Stockholders Equity | 56.45B | 57.43B | 55.86B | 56.83B | 54.20B | 54.75B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 745.00M | 14.90B | 0.00 | -110.62B | 90.10B |
| Operating Cash Flow | 0.00 | 1.35B | 15.32B | 0.00 | -110.25B | 90.73B |
| Investing Cash Flow | 0.00 | -21.54B | -26.13B | 8.86B | 2.06B | -13.00M |
| Financing Cash Flow | 0.00 | 21.28B | 17.39B | 17.55B | -828.00M | 2.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥26.77B | 9.65 | ― | 3.50% | 1.03% | 12.15% | |
69 Neutral | ¥13.84B | 8.73 | ― | 3.30% | 20.18% | 20.57% | |
68 Neutral | ¥12.41B | 7.38 | ― | 3.74% | 15.32% | 26.30% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | ¥13.19B | 7.78 | ― | 3.58% | 18.86% | 59.05% | |
59 Neutral | ¥17.13B | 14.62 | ― | 3.37% | 6.15% | -0.87% | |
52 Neutral | ¥11.96B | 16.25 | ― | 1.89% | 17.42% | ― |